Arquivamento - Art. 36 §1° da LPI
#11.2
12/17/2024
RPI 2815
Application data
Number
112019025188Type
Filing
Publication
PCT
US2018035508 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.
Applicants
CYTOMX THERAPEUTICS, INC.
US
Inventors
B. Z. (pessoa física)
US
K. B. (pessoa física)
US
L. C. (pessoa física)
US
M. W. (pessoa física)
US
R. H. (pessoa física)
US
IPC Classification
Priority claims
US
62/513,937 · 06/01/2017
US
62/534,950 · 07/20/2017
US
62/555,598 · 09/07/2017
US
62/657,567 · 04/13/2018
Abstract
A invenção refere-se geralmente a anticorpos ativáveis que se ligam especificamente ao PDL1 e a métodos para fabricar e usar estes anticorpos ativáveis anti-PDL1 em uma variedade de indicações terapêuticas, diagnósticas e profiláticas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
12/17/2024
RPI 2815
#6.23
08/27/2024
RPI 2799
#15.35
11/03/2021
RPI 2652
#1.3
06/23/2020
RPI 2581
#1.1
12/10/2019
RPI 2553
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.